Multiple roles of the capsid protein in the early steps of HIV-1 infection

Virus Research

Volumn 170, Issue 1-2, 2012, Pages 15-24

  Fassati, Ariberto ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Capsid; Cyclophilin; HIV 1; Integration; Nuclear import; Tnpo3; Uncoating

Indexed keywords

CAPSID PROTEIN;

CHROMOSOME; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; VIRUS CORE; VIRUS ENTRY; VIRUS TRANSMISSION;

ACTIVE TRANSPORT, CELL NUCLEUS; CAPSID PROTEINS; CELL NUCLEUS; HIV INFECTIONS; HIV-1; HUMANS; REVERSE TRANSCRIPTION; VIRUS INTEGRATION; VIRUS UNCOATING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84870440074     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.09.012     Document Type: Review

References (106)

1. Aberham C., Weber S., Phares W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. Journal of Virology 1996, 70(6):3536-3544.
2. Aiken C. Cell-free assays for HIV-1 uncoating. Methods in Molecular Biology 2009, 485:41-53.
3. Ambrose Z., Lee K., Ndjomou J., Xu H., Oztop I., Matous J., Takemura T., Unutmaz D., Engelman A., Hughes S.H., Kewalramani V.N. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. Journal of Virology 2012, 86(8):4708-4714.
4. Arfi V., Lienard J., Nguyen X.N., Berger G., Rigal D., Darlix J.L., Cimarelli A. Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. Journal of Virology 2009, 83(15):7524-7535.
5. Arhel N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7:96.
6. Arhel N.J., Souquere-Besse S., Munier S., Souque P., Guadagnini S., Rutherford S., Prevost M.C., Allen T.D., Charneau P. HIV-1 DNA flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO Journal 2007, 26(12):3025-3037.
7. Berthet-Colominas C., Monaco S., Novelli A., Sibai G., Mallet F., Cusack S. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO Journal 1999, 18(5):1124-1136.
8. Bharat T.A., Davey N.E., Ulbrich P., Riches J.D., de Marco A., Rumlova M., Sachse C., Ruml T., Briggs J.A. Structure of the immature retroviral capsid at 8 A resolution by cryo-electron microscopy. Nature 2012, 487(7407):385-389.
9. Blair W.S., Pickford C., Irving S.L., Brown D.G., Anderson M., Bazin R., Cao J., Ciaramella G., Isaacson J., Jackson L., Hunt R., Kjerrstrom A., Nieman J.A., Patick A.K., Perros M., Scott A.D., Whitby K., Wu H., Butler S.L. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathogens 2010, 6(12):e1001220.
10. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(8):5247-5252.
11. Bowerman B., Brown P.O., Bishop J.M., Varmus H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes and Development 1989, 3(4):469-478.
12. Braaten D., Aberham C., Franke E.K., Yin L., Phares W., Luban J. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. Journal of Virology 1996, 70(8):5170-5176.
13. Braaten D., Franke E.K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. Journal of Virology 1996, 70(6):3551-3560.
14. Braaten D., Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO Journal 2001, 20(6):1300-1309.
15. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
16. Briggs J.A., Krausslich H.G. The molecular architecture of HIV. Journal of Molecular Biology 2011, 410(4):491-500.
17. Briggs J.A., Simon M.N., Gross I., Krausslich H.G., Fuller S.D., Vogt V.M., Johnson M.C. The stoichiometry of Gag protein in HIV-1. Nature Structural & Molecular Biology 2004, 11(7):672-675.
18. Briggs J.A., Wilk T., Welker R., Krausslich H.G., Fuller S.D. Structural organization of authentic, mature HIV-1 virions and cores. EMBO Journal 2003, 22(7):1707-1715.
19. Bukovsky A.A., Weimann A., Accola M.A., Gottlinger H.G. Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(20):10943-10948.
20. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(13):6125-6129.
21. Christ F., Thys W., De Rijck J., Gijsbers R., Albanese A., Arosio D., Emiliani S., Rain J.C., Benarous R., Cereseto A., Debyser Z. Transportin-SR2 imports HIV into the nucleus. Current Biology 2008, 18(16):1192-1202.
22. De Iaco A., Luban J. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology 2011, 8:98.
23. Dismuke D.J., Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. Journal of Virology 2006, 80(8):3712-3720.
24. Engelman A., Cherepanov P. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathogens 2008, 4(3):e1000046.
25. Farnet C.M., Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. Journal of Virology 1991, 65(4):1910-1915.
26. Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology 2006, 3:74.
27. Fassati A., Goff S.P. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. Journal of Virology 1999, 73(11):8919-8925.
28. Fassati A., Goff S.P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. Journal of Virology 2001, 75(8):3626-3635.
29. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989, 337(6206):476-478.
30. Forshey B.M., von Schwedler U., Sundquist W.I., Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. Journal of Virology 2002, 76(11):5667-5677.
31. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372(6504):359-362.
32. Freed E.O., Martin M.A. HIVs and their replication. Fields Virology 2001, vol. 2:1971-2042. Lippincott Williams & Wilkins, Philadelphia.
33. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87(7):1285-1294.
34. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278(5339):849-853.
35. Ganser B.K., Li S., Klishko V.Y., Finch J.T., Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283(5398):80-83.
36. Ganser-Pornillos B.K., Cheng A., Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 2007, 131(1):70-79.
37. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996, 273(5272):231-235.
38. Goldstone D.C., Yap M.W., Robertson L.E., Haire L.F., Taylor W.R., Katzourakis A., Stoye J.P., Taylor I.A. Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host & Microbe 2010, 8(3):248-259.
39. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annual Review of Cell and Developmental Biology 1999, 15:607-660.
40. Grattinger M., Hohenberg H., Thomas D., Wilk T., Muller B., Krausslich H.G. In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. Virology 1999, 257(1):247-260.
41. Gross I., Hohenberg H., Huckhagel C., Krausslich H.G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. Journal of Virology 1998, 72(6):4798-4810.
42. Hatziioannou T., Perez-Caballero D., Cowan S., Bieniasz P.D. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. Journal of Virology 2005, 79(1):176-183.
43. Hulme A.E., Perez O., Hope T.J. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(24):9975-9980.
44. Jager S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., Hernandez H., Jang G.M., Roth S.L., Akiva E., Marlett J., Stephens M., D'Orso I., Fernandes J., Fahey M., Mahon C., O'Donoghue A.J., Todorovic A., Morris J.H., Maltby D.A., Alber T., Cagney G., Bushman F.D., Young J.A., Chanda S.K., Sundquist W.I., Kortemme T., Hernandez R.D., Craik C.S., Burlingame A., Sali A., Frankel A.D., Krogan N.J. Global landscape of HIV-human protein complexes. Nature 2012, 481(7381):365-370.
45. Jin Y., Tan Z., He M., Tian B., Tang S., Hewlett I., Yang M. SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA. Bioorganic and Medicinal Chemistry 2010, 18(6):2135-2140.
46. Karageorgos L., Li P., Burrell C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Research and Human Retroviruses 1993, 9(9):817-823.
47. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60.
48. Koning F.A., Goujon C., Bauby H., Malim M.H. Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. Journal of Virology 2011, 85(24):13448-13452.
49. Kortagere S., Madani N., Mankowski M.K., Schon A., Zentner I., Swaminathan G., Princiotto A., Anthony K., Oza A., Sierra L.J., Passic S.R., Wang X., Jones D.M., Stavale E., Krebs F.C., Martin-Garcia J., Freire E., Ptak R.G., Sodroski J., Cocklin S., Smith A.B. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. Journal of Virology 2012, 86(16):8472-8481.
50. Krishnan L., Matreyek K.A., Oztop I., Lee K., Tipper C.H., Li X., Dar M.J., Kewalramani V.N., Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. Journal of Virology 2010, 84(1):397-406.
51. Lammers M., Neumann H., Chin J.W., James L.C. Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization. Nature Chemical Biology 2010, 6(5):331-337.
52. Lee K., Ambrose Z., Martin T.D., Oztop I., Mulky A., Julias J.G., Vandegraaff N., Baumann J.G., Wang R., Yuen W., Takemura T., Shelton K., Taniuchi I., Li Y., Sodroski J., Littman D.R., Coffin J.M., Hughes S.H., Unutmaz D., Engelman A., Kewalramani V.N. Flexible use of nuclear import pathways by HIV-1. Cell Host & Microbe 2010, 7(3):221-233.
53. Lee K., Mulky A., Yuen W., Martin T.D., Meyerson N.R., Choi L., Yu H., Sawyer S.L., Kewalramani V.N. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. Journal of Virology 2012, 86(7):3851-3860.
54. Lemke C.T., Titolo S., von Schwedler U., Goudreau N., Mercier J.F., Wardrop E., Faucher A.M., Coulombe R., Banik S.S., Fader L., Gagnon A., Kawai S.H., Rancourt J., Tremblay M., Yoakim C., Simoneau B., Archambault J., Sundquist W.I., Mason S.W. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. Journal of Virology 2012, 86(12):6643-6655.
55. Li Y., Kar A.K., Sodroski J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. Journal of Virology 2009, 83(21):10951-10962.
56. Logue E.C., Taylor K.T., Goff P.H., Landau N.R. The cargo-binding domain of transportin 3 is required for lentivirus nuclear import. Journal of Virology 2011, 85(24):12950-12961.
57. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73(6):1067-1078.
58. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences 2009, 364(1517):675-687.
59. Malim M.H., Bieniasz P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harbor Perspectives in Medicine 2012, 2(5):a006940.
60. Matreyek K.A., Engelman A. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. Journal of Virology 2011, 85(15):7818-7827.
61. Matsuoka S., Dam E., Lecossier D., Clavel F., Hance A.J. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type. Retrovirology 2009, 6:21.
62. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., Hope T.J. Visualization of the intracellular behavior of HIV in living cells. Journal of Cell Biology 2002, 159(3):441-452.
63. Meehan A.M., Saenz D.T., Morrison J., Hu C., Peretz M., Poeschla E.M. LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity. Journal of Virology 2011, 85(7):3570-3583.
64. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. Journal of Virology 1997, 71(7):5382-5390.
65. Momany C., Kovari L.C., Prongay A.J., Keller W., Gitti R.K., Lee B.M., Gorbalenya A.E., Tong L., McClure J., Ehrlich L.S., Summers M.F., Carter C., Rossmann M.G. Crystal structure of dimeric HIV-1 capsid protein. Natural Structural Biology 1996, 3(9):763-770.
66. Nermut M.V., Fassati A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. Journal of Virology 2003, 77(15):8196-8206.
67. Ocwieja K.E., Brady T.L., Ronen K., Huegel A., Roth S.L., Schaller T., James L.C., Towers G.J., Young J.A., Chanda S.K., Konig R., Malani N., Berry C.C., Bushman F.D. HIV integration targeting: a pathway involving transportin-3 and the nuclear pore protein RanBP2. PLoS Pathogens 2011, 7(3):e1001313.
68. Perez-Caballero D., Hatziioannou T., Zhang F., Cowan S., Bieniasz P.D. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. Journal of Virology 2005, 79(24):15567-15572.
69. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A., Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M., Grutter M.G., Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472(7343):361-365.
70. Pornillos O., Ganser-Pornillos B.K., Kelly B.N., Hua Y., Whitby F.G., Stout C.D., Sundquist W.I., Hill C.P., Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137(7):1282-1292.
71. Pornillos O., Ganser-Pornillos B.K., Yeager M. Atomic-level modelling of the HIV capsid. Nature 2011, 469(7330):424-427.
72. Price A.J., Fletcher A.J., Schaller T., Elliott T., Lee K., Kewalramani V.N., Chin J.W., Towers G.J., James L.C. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathogens 2012, 8(8):e1002896.
73. Prizan-Ravid A., Elis E., Laham-Karam N., Selig S., Ehrlich M., Bacharach E. The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex. PLoS Pathogens 2010, 6(11):e1001183.
74. Ptak R.G., Gallay P.A., Jochmans D., Halestrap A.P., Ruegg U.T., Pallansch L.A., Bobardt M.D., de Bethune M.P., Neyts J., De Clercq E., Dumont J.M., Scalfaro P., Besseghir K., Wenger R.M., Rosenwirth B. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrobial Agents and Chemotherapy 2008, 52(4):1302-1317.
75. Qi M., Yang R., Aiken C. Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells. Journal of Virology 2008, 82(24):12001-12008.
76. Roa A., Hayashi F., Yang Y., Lienlaf M., Zhou J., Shi J., Watanabe S., Kigawa T., Yokoyama S., Aiken C., Diaz-Griffero F. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. Journal of Virology 2012, 86(3):1717-1727.
77. Rosenwirth B., Billich A., Datema R., Donatsch P., Hammerschmid F., Harrison R., Hiestand P., Jaksche H., Mayer P., Peichl P., et al. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrobial Agents and Chemotherapy 1994, 38(8):1763-1772.
78. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., Hue S., Fletcher A.J., Lee K., Kewalramani V.N., Noursadeghi M., Jenner R.G., James L.C., Bushman F.D., Towers G.J. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathogens 2011, 7(12):e1002439.
79. Schaller T., Ylinen L.M., Webb B.L., Singh S., Towers G.J. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses. Journal of Virology 2007, 81(18):10055-10063.
80. Shi J., Zhou J., Shah V.B., Aiken C., Whitby K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. Journal of Virology 2011, 85(1):542-549.
81. Sokolskaja E., Sayah D.M., Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. Journal of Virology 2004, 78(23):12800-12808.
82. Sticht J., Humbert M., Findlow S., Bodem J., Muller B., Dietrich U., Werner J., Krausslich H.G. A peptide inhibitor of HIV-1 assembly in vitro. Nature Structural & Molecular Biology 2005, 12(8):671-677.
83. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(14):5514-5519.
84. Tang C., Loeliger E., Kinde I., Kyere S., Mayo K., Barklis E., Sun Y., Huang M., Summers M.F. Antiviral inhibition of the HIV-1 capsid protein. Journal of Molecular Biology 2003, 327(5):1013-1020.
85. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372(6504):363-365.
86. Towers G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40.
87. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nature Medicine 2003, 9(9):1138-1143.
88. Valente S.T., Gilmartin G.M., Mott C., Falkard B., Goff S.P. Inhibition of HIV-1 replication by eIF3f. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(11):4071-4078.
89. Valle-Casuso J.C., Di Nunzio F., Yang Y., Reszka N., Lienlaf M., Arhel N., Perez P., Brass A.L., Diaz-Griffero F. TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core. Journal of Virology 2012, 86(10):5931-5936.
90. Vozzolo L., Loh B., Gane P.J., Tribak M., Zhou L., Anderson I., Nyakatura E., Jenner R.G., Selwood D., Fassati A. Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. Journal of Biological Chemistry 2010, 285(50):39314-39328.
91. Wainberg M.A., Dascal A., Blain N., Fitz-Gibbon L., Boulerice F., Numazaki K., Tremblay M. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood 1988, 72(6):1904-1910.
92. Warren K., Wei T., Li D., Qin F., Warrilow D., Lin M.H., Sivakumaran H., Apolloni A., Abbott C.M., Jones A., Anderson J.L., Harrich D. Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(24):9587-9592.
93. Wiegers K., Rutter G., Schubert U., Grattinger M., Krausslich H.G. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. Virology 1999, 257(1):261-274.
94. Wu J., Matunis M.J., Kraemer D., Blobel G., Coutavas E. Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. The Journal of Biological Chemistry 1995, 270(23):14209-14213.
95. Yamashita M., Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. Journal of Virology 2004, 78(11):5670-5678.
96. Yamashita M., Emerman M. Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells. Journal of Virology 2009, 83(19):9835-9843.
97. Yamashita M., Perez O., Hope T.J., Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathogens 2007, 3(10):1502-1510.
98. Yang R., Aiken C. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. Journal of Virology 2007, 81(8):3749-3756.
99. Yap M.W., Dodding M.P., Stoye J.P. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. Journal of Virology 2006, 80(8):4061-4067.
100. Yeager M., Wilson-Kubalek E.M., Weiner S.G., Brown P.O., Rein A. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(13):7299-7304.
101. Yin L., Braaten D., Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. Journal of Virology 1998, 72(8):6430-6436.
102. Zaitseva L., Cherepanov P., Leyens L., Wilson S.J., Rasaiyaah J., Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 2009, 6:11.
103. Zaitseva L., Myers R., Fassati A. tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes. PLoS Biology 2006, 4(10):e332.
104. Zhang R., Mehla R., Chauhan A. Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus-1 preintegration complex (DNA). PLoS ONE 2010, 5(12):e15620.
105. Zhou, L., Chen, N-Y., Gane, P.G., Price, A., Lamorte, L., Zufferey, M., Luban, J., James, L., Selwood, D. and Fassati, A., 2012. Small molecule inhibition of HIV-1 integration by targeting the viral capsid. In preparation.
106. Zhou L., Sokolskaja E., Jolly C., James W., Cowley S.A., Fassati A. Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathogens 2011, 7(8):e1002194.